Depo-Provera: Wall Chart Poster for Providers [Swahili] Poster with key information about Depo-Provera, including messaging on potential increased risk of HIV acquisition. This tool was developed for a pilot study with providers in Tanzania. ...
Injectable Birth Control Increases HIV Risk by 40% This article summarizes evidence from the Hapgood study concluding that women using the injectable progestin contraceptive depot medroxyprogesterone acetate, or DMPA, may face a substantially elevated risk for HIV...
Real Women Don’t Look Like Models: What the latest paper on hormonal contraception and HIV risk leaves out By Emily Bass As the Echo trial continues its investigation on certain hormonal contraceptives and the possibility they increase the risk of acquiring HIV,...
WHO-Sponsored Webinar on DMPA NET EN & HIV Acquisition This is a special follow-up on the on the DMPA Net EN meeting on 12 December 2017. Published: 2018 Source: WHO Back to...
Common Birth Control Shot Linked to Risk of HIV Infection By Jeff Hansen Transitioning away from a popular contraceptive shot known as DMPA could help protect women in Sub-Saharan Africa and other high-risk regions from becoming infected with HIV, according to new...
Recent Comments